Chronic granulomatous disease (CGD) is a rare, primary immune deficiency rendering the affected individuals hypersusceptible to bacterial and fungal infections. The underlying defect is an inherited inability of the patients' phagocytes to produce the reactive oxygen species (ROS) that are necessary for the full antimicrobial action of these cells. The ROS are normally produced by a membrane-bound enzyme complex, the NADPH-oxidase. Certain mutations in genes encoding this enzyme result in a nonfunctional oxidase and thereby abrogated ROS production and diminished bactericidal capacity. In addition to increased susceptibility to infection, CGD patients also regularly suffer from a number of different inflammatory complications, such as granuloma formation, inflammatory bowel disease, and lupus-like syndromes. These latter symptoms likely stem from what seems to be a propensity for exaggerated inflammatory reactions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc
About this paper
Cite this paper
Bylund, J., Goldblatt, D., Speert, D.P. (2005). Chronic Granulomatous Disease: From Genetic Defect to Clinical Presentation. In: Pollard, A.J., Finn, A. (eds) Hot Topics in Infection and Immunity in Children II. Advances in Experimental Medicine and Biology, vol 568. Springer, Boston, MA. https://doi.org/10.1007/0-387-25342-4_5
Download citation
DOI: https://doi.org/10.1007/0-387-25342-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25341-1
Online ISBN: 978-0-387-25342-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)